MDGL
MDGL438.900USD
-3.230-0.73%
終値 10/17, 16:00（ET）15分遅れの株価
9.75B時価総額
--直近12ヶ月PER
詳細情報 Madrigal Pharmaceuticals Inc 企業名
MDGLの企業情報
企業コードMDGL
会社名Madrigal Pharmaceuticals Inc
上場日Feb 06, 2007
最高経営責任者「CEO」Mr. Bill Sibold
従業員数528
証券種類Ordinary Share
決算期末Feb 06
本社所在地200 Barr Harbor Dr Ste 400
都市WEST CONSHOHOCKEN
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号19428-2978
電話番号14043809263
ウェブサイトhttps://www.madrigalpharma.com/
企業コードMDGL
上場日Feb 06, 2007
最高経営責任者「CEO」Mr. Bill Sibold
MDGLの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Director
Director
442.32K
--
Dr. Paul A. Friedman, M.D.
Dr. Paul A. Friedman, M.D.
Director
Director
165.12K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
11.38K
+6.70%
Dr. David Soergel, M.D.
Dr. David Soergel, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
7.54K
--
Mr. Raymond Cheong, M.D., Ph.D.
Mr. Raymond Cheong, M.D., Ph.D.
Independent Director
Independent Director
2.40K
--
Mr. Kenneth M. (Ken) Bate
Mr. Kenneth M. (Ken) Bate
Independent Director
Independent Director
1.91K
--
Ms. Shannon Kelley
Ms. Shannon Kelley
Executive Vice President, Chief Legal Counsel
Executive Vice President, Chief Legal Counsel
--
-100.00%
Mr. James M. Daly
Mr. James M. Daly
Independent Director
Independent Director
--
--
Mr. Julian C. Baker
Mr. Julian C. Baker
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bill Sibold
Mr. Bill Sibold
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Director
Director
442.32K
--
Dr. Paul A. Friedman, M.D.
Dr. Paul A. Friedman, M.D.
Director
Director
165.12K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
11.38K
+6.70%
Dr. David Soergel, M.D.
Dr. David Soergel, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
7.54K
--
Mr. Raymond Cheong, M.D., Ph.D.
Mr. Raymond Cheong, M.D., Ph.D.
Independent Director
Independent Director
2.40K
--
Mr. Kenneth M. (Ken) Bate
Mr. Kenneth M. (Ken) Bate
Independent Director
Independent Director
1.91K
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
Janus Henderson Investors
9.83%
Baker Bros. Advisors LP
9.61%
Paulson & Co. Inc.
9.37%
RTW Investments L.P.
8.94%
Avoro Capital Advisors LLC
8.41%
他の
53.83%
株主統計
株主統計
比率
Janus Henderson Investors
9.83%
Baker Bros. Advisors LP
9.61%
Paulson & Co. Inc.
9.37%
RTW Investments L.P.
8.94%
Avoro Capital Advisors LLC
8.41%
他の
53.83%
種類
株主統計
比率
Investment Advisor/Hedge Fund
43.34%
Investment Advisor
33.35%
Hedge Fund
17.09%
Family Office
9.38%
Individual Investor
4.73%
Corporation
2.94%
Research Firm
2.40%
Sovereign Wealth Fund
0.79%
Pension Fund
0.65%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
637
21.95M
98.48%
-2.20M
2025Q2
650
23.67M
106.20%
-1.56M
2025Q1
668
23.83M
107.57%
-1.54M
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Janus Henderson Investors
2.19M
9.83%
-14.10K
-0.64%
Jun 30, 2025
Baker Bros. Advisors LP
2.14M
9.61%
+165.68K
+8.38%
Aug 20, 2025
Paulson & Co. Inc.
2.09M
9.37%
-10.00K
-0.48%
Jun 30, 2025
RTW Investments L.P.
1.99M
8.94%
--
--
Jun 30, 2025
Avoro Capital Advisors LLC
1.88M
8.41%
-147.22K
-7.28%
Jun 30, 2025
The Vanguard Group, Inc.
1.87M
8.41%
+186.99K
+11.08%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.26M
5.63%
-59.53K
-4.53%
Jun 30, 2025
State Street Investment Management (US)
690.72K
3.1%
-67.80K
-8.94%
Jun 30, 2025
SQN, L.L.C.
655.54K
2.94%
--
--
Apr 01, 2025
UBS Financial Services, Inc.
502.21K
2.25%
+211.75K
+72.90%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Mon, Oct 6
更新時刻: Mon, Oct 6
銘柄名
比率
Innovator IBD Breakout Opportunities ETF
3.5%
SPDR S&P Biotech ETF
2.6%
Virtus LifeSci Biotech Products ETF
2.45%
Direxion Daily S&P Biotech Bull 3X Shares
1.58%
Tema Heart & Health ETF
1.5%
Global X Guru Index ETF
1.45%
Goldman Sachs Future Health Care Equity ETF
1.11%
Invesco Nasdaq Biotechnology ETF
0.99%
ProShares Ultra Nasdaq Biotechnology
0.99%
First Trust Innovation Leaders ETF
0.87%
詳細を見る
Innovator IBD Breakout Opportunities ETF
比率3.5%
SPDR S&P Biotech ETF
比率2.6%
Virtus LifeSci Biotech Products ETF
比率2.45%
Direxion Daily S&P Biotech Bull 3X Shares
比率1.58%
Tema Heart & Health ETF
比率1.5%
Global X Guru Index ETF
比率1.45%
Goldman Sachs Future Health Care Equity ETF
比率1.11%
Invesco Nasdaq Biotechnology ETF
比率0.99%
ProShares Ultra Nasdaq Biotechnology
比率0.99%
First Trust Innovation Leaders ETF
比率0.87%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
